Fitzpatrick Michael, Sadiq Hammad, Rampam Sanjeev, Araia Almaz, Miller Megan, Vargas Kevin Rivera, Fry Patrick, Smith Anne Marie, Lowe Mary Martin, Catalano Christina, Harrison Charles, Catanzaro John, Crawford Sybil, McManus David, Kapoor Alok
Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
Department of Medicine, University of Massachusetts Memorial Health Care, Worcester, Massachusetts.
Cardiovasc Digit Health J. 2022 Aug 3;3(5):241-246. doi: 10.1016/j.cvdhj.2022.07.068. eCollection 2022 Oct.
The main approach to preventing stroke in patients with atrial fibrillation (AF) is anticoagulation (AC), but only about 60% of at-risk individuals are on AC. Patient-facing electronic health record-based interventions have produced mixed results. Little is known about the impact of health portal-based messaging on AC use.
The purpose of this study was describe a protocol we will use to measure the association between AC use and patient portal message opening. We also will measure patient attitudes toward education materials housed on a professional society Web site.
We will send portal messages to patients aged ≥18 years with AF 1 week before an office/teleconference visit with a primary care or cardiology provider. The message will be customized for 3 groups of patients: those on AC; those at elevated risk but off AC; and those not currently at risk but may be at risk in the future. Within the message, we will embed a link to UpBeat.org, a Web site of the Heart Rhythm Society containing patient educational materials. We also will embed a link to a survey. Among other things, the survey will request patients to rate their attitude toward the Heart Rhythm Society Web pages. To measure the effectiveness of the intervention, we will track AC use and its association with message opening, adjusting for potential confounders.
If we detect an increase in AC use correlates with message opening, we will be well positioned to conduct a future comparative effectiveness trial. If patients rate the UpBeat.org materials highly, patients from other institutions also may benefit from receiving these materials.
心房颤动(AF)患者预防中风的主要方法是抗凝治疗(AC),但只有约60%的高危个体接受了抗凝治疗。以患者为导向的基于电子健康记录的干预措施产生了不同的结果。关于基于健康门户网站的信息对抗凝治疗使用的影响知之甚少。
本研究的目的是描述一种方案,我们将使用该方案来衡量抗凝治疗使用与患者门户网站信息打开之间的关联。我们还将衡量患者对专业协会网站上教育材料的态度。
我们将在患者与初级保健或心脏病学提供者进行办公室/电话会议就诊前1周,向年龄≥18岁的房颤患者发送门户网站信息。该信息将针对3组患者进行定制:接受抗凝治疗的患者;风险升高但未接受抗凝治疗的患者;以及目前无风险但未来可能有风险的患者。在信息中,我们将嵌入一个链接到UpBeat.org,这是心律协会的一个网站,包含患者教育材料。我们还将嵌入一个调查链接。除其他事项外,该调查将要求患者对他们对心律协会网页的态度进行评分。为了衡量干预措施的有效性,我们将跟踪抗凝治疗的使用情况及其与信息打开的关联,并对潜在的混杂因素进行调整。
如果我们发现抗凝治疗使用的增加与信息打开相关,我们将有充分的条件进行未来的比较有效性试验。如果患者对UpBeat.org的材料评价很高,其他机构的患者也可能从接收这些材料中受益。